Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Updated the Study Details page to include results-related sections and new timing information. Dates for enrollment, primary completion, and study completion have been updated.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:49.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    The page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-05T10:27:10.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:18:51.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, indicating a version upgrade. The removal of 'Back to Top' is a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:45:31.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T15:32:15.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has added significant content related to antibodies and proteins, including specific types and categories, while removing extensive information on various hematologic diseases and related medical topics.
    Difference
    4%
    Check dated 2025-08-30T12:12:51.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.